Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label patents. Show all posts
Showing posts with label patents. Show all posts
Wednesday, May 09, 2012

Myriad RBM Announces the Launch of OncologyMAP® v. 2.0

›
Myriad RBM Announces the Launch of OncologyMAP® v. 2.0 Myriad Genetics (NASDAQ: MYGN) announced today that Myriad RBM, a wholly owned sub...
Saturday, May 05, 2012

paywalled: US firm corners exclusive license for RAD51C cancer gene : The Lancet Oncology (breast/ovarian mutation)

›
US firm corners exclusive license for RAD51C cancer gene : The Lancet Oncology US firm corners exclusive license for RAD51C cancer ge...
Monday, April 16, 2012

press release: (OVA1) Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer

›
Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer (press release) About OVA1 ...
Tuesday, March 27, 2012

media: AMP Optimistic in Suit to invalidate Patents on Breast Cancer Genes (BRCA/ovarian....)

›
Blogger's Note: typical reminder that the Myriad 'breast cancer' genetic testing is not only for breast cancer AMP Optimist...
Monday, March 26, 2012

Reuters: Myriad gene patent ruling sent back to lower court

›
  Reuters: Myriad gene patent ruling sent back to lower court "The move is expected to delay a verdict in the Myriad case by as much ...

Supreme Court Ruling Creates Uncertainty for Diagnostics Companies - 03/23/2012 - The Burrill Report

›
Supreme Court Ruling Creates Uncertainty for Diagnostics Companies - 03/23/2012 - The Burrill Report
Friday, March 23, 2012

Myriad Genetics slips on patent concerns - BusinessWeek

›
Myriad Genetics slips on patent concerns - BusinessWeek
Thursday, March 22, 2012

ImmunoCellular Therapeutics Licenses Novel Immunotherapeutic Target EphA2 from University of Pittsburgh - MarketWatch

›
ImmunoCellular Therapeutics Licenses Novel Immunotherapeutic Target EphA2 from University of Pittsburgh - MarketWatch ImmunoCellular The...
Tuesday, March 20, 2012

Mayo Clinic - Mayo Clinic Reacts to Unanimous Supreme Court Decision (patents/Prometheus/blood test)

›
Mayo Clinic - Mayo Clinic Reacts to Unanimous Supreme Court Decision Mayo Clinic Reacts to Unanimous Supreme Court Decision Tuesday, M...

Supreme court rules against Nestle unit (Prometheus Laboratories) on patent

›
Reuters: Supreme court rules against Nestle unit on patent WASHINGTON | Tue Mar 20, 2012 10:32am EDT (Reuters) - T...
Monday, March 12, 2012

Blogger: “And you’re ugly too” | genomeboy (genetic testing/patents, brca....)

›
“And you’re ugly too” | genomeboy "All of this, of course, was precipitated by AMP v. USPTO (“The Myriad Case”) , in which patients...
Friday, March 02, 2012

[Lancet Oncology News] US firm corners exclusive license for RAD51C cancer gene

›
[News] US firm corners exclusive license for RAD51C cancer gene : "Already facing a legal challenge to its BRCA1 and BRCA2 patents...
Friday, February 17, 2012

Patents on Genetic Data Raise Legal Questions on Rights to DNA - Bloomberg

›
Thursday, February 16, 2012

Is Myriad’s Patent On Breast Cancer Genes Valid? | CT Health I-Team (some things you may not know)

›
Thursday, January 26, 2012

Jan 2012 BRCA patent dispute may head to US Supreme Court : The Lancet

›
"The long-running dispute over patents for the BRCA1 and BRCA2 genes granted to Myriad Genetics may finally be laid to rest by the US...
Saturday, December 31, 2011

Year in Review: Gene Patent Case May Head to Supreme Court - Myriad + Mayo/Prometheus Labs

›
Friday, July 29, 2011

Gene Patent (Myriad) in Cancer Test Upheld by Appeals Panel - NYTimes.com (BRCA 1/2)

›
Friday, March 04, 2011

Genetics Company Myriad May Shift From Patents To Proprietary Data | Intellectual Property Watch

›
Friday, December 24, 2010

New Candidate Antibody-Drug Conjugate Gains Broad Patent Coverage - financial news (EGP-1 or TROP-2)

›
Tuesday, December 21, 2010

Court Backs Patents for Diagnostic Tests - NYTimes.com

›